How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
21
SNN Quote, Financials, Valuation and Earnings
Last price:
$24.46
Seasonality move
:
2.62%
Day range:
$24.26 - $24.52
52-week range:
$23.65 - $31.72
Dividend yield:
3.07%
P/E ratio:
35.01x
P/S ratio:
1.89x
P/B ratio:
2.05x
Volume:
317.9K
Avg. volume:
823.8K
1-year change:
-10.83%
Market cap:
$10.7B
Revenue:
$5.5B
EPS (TTM):
$0.70
Analysts' Opinion
-
Consensus RatingSmith & Nephew PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $35.35, Smith & Nephew PLC has an estimated upside of 33.2% from its current price of $24.46.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $24.46.
Fair Value
-
According to the consensus of 4 analysts, Smith & Nephew PLC has 33.2% upside to fair value with a price target of $35.35 per share.
SNN vs. S&P 500
-
Over the past 5 trading days, Smith & Nephew PLC has underperformed the S&P 500 by -6.68% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Smith & Nephew PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Smith & Nephew PLC has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Smith & Nephew PLC reported revenues of --.
Earnings Growth
-
Smith & Nephew PLC earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Smith & Nephew PLC reported earnings per share of --.
Enterprise value:
13.6B
EV / Invested capital:
--
Price / LTM sales:
1.89x
EV / EBIT:
28.31x
EV / Revenue:
2.40x
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
13.65x
Gross Profit (TTM):
$3.9B
Return On Assets:
3.01%
Net Income Margin (TTM):
5.41%
Return On Equity:
5.85%
Return On Invested Capital:
3.68%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $1.2B | $1.2B | |
| Gross Profit | -- | -- | -- | $882M | $940M | |
| Operating Income | -- | -- | -- | $307M | $372M | |
| EBITDA | -- | -- | -- | $332M | $353M | |
| Diluted EPS | -- | -- | -- | $0.36 | $0.36 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.3B | $4.4B | $3.8B | $3.9B | $4.5B | |
| Total Assets | $9.5B | $10.9B | $10.1B | $9.8B | $10.5B | |
| Current Liabilities | $1.5B | $2.1B | $2.1B | $1.8B | $1.8B | |
| Total Liabilities | $4.6B | $5.6B | $4.7B | $4.6B | $5.3B | |
| Total Equity | $5B | $5.3B | $5.4B | $5.2B | $5.2B | |
| Total Debt | $2.4B | $3.4B | $2.7B | $2.8B | $3.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $321M | $302M | |
| Cash From Investing | -- | -- | -- | -$199M | $85M | |
| Cash From Financing | -- | -- | -- | -$112M | -$426M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SNN
Sector
Market Cap
$10.7B
$46.1M
Price % of 52-Week High
77.05%
46.02%
Dividend Yield
3.07%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-10.41%
-30.52%
Beta (5-Year)
0.845
0.772
Dividend yield:
3.07%
Annualized payout:
$0.75
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$24.82
200-day SMA
Sell
Level
$27.05
Bollinger Bands (100)
Sell
Level
25.63 - 30.77
Chaikin Money Flow
Buy
Level
61.9M
20-day SMA
Sell
Level
$25.28
Relative Strength Index (RSI14)
Sell
Level
32.56
ADX Line
Sell
Level
30.96
Williams %R
Buy
Level
-98.7179
50-day SMA
Sell
Level
$26.00
MACD (12, 26)
Sell
Level
-0.39
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
125.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0923)
Buy
CA Score
(Annual)
Level (0.0618)
Buy
Beneish M-Score
(Annual)
Level (-2.6242)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.0628)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Stock Forecast FAQ
In the current month, SNN has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The SNN average analyst price target in the past 3 months is $35.35.
-
Where Will Smith & Nephew PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Smith & Nephew PLC share price will rise to $35.35 per share over the next 12 months.
-
What Do Analysts Say About Smith & Nephew PLC?
Analysts are divided on their view about Smith & Nephew PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smith & Nephew PLC is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Smith & Nephew PLC's Price Target?
The price target for Smith & Nephew PLC over the next 1-year time period is forecast to be $35.35 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is SNN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Smith & Nephew PLC is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SNN?
You can purchase shares of Smith & Nephew PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smith & Nephew PLC shares.
-
What Is The Smith & Nephew PLC Share Price Today?
Smith & Nephew PLC was last trading at $24.46 per share. This represents the most recent stock quote for Smith & Nephew PLC. Yesterday, Smith & Nephew PLC closed at $24.46 per share.
-
How To Buy Smith & Nephew PLC Stock Online?
In order to purchase Smith & Nephew PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
